Total Payments
$15,130
2024 Payments
$1,331
Companies
19
Transactions
262
Medicare Patients
1,731
Medicare Billing
$559,041
Payment Breakdown by Category
Food & Beverage$15,068 (99.6%)
Education$61.49 (0.4%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,068 | 260 | 99.6% |
| Education | $61.49 | 2 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $3,021 | 32 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $2,462 | 36 | $0 (2021) |
| Neurocrine Biosciences, Inc. | $2,170 | 27 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $2,047 | 18 | $0 (2024) |
| Allergan Inc. | $988.39 | 19 | $0 (2019) |
| Lundbeck LLC | $620.11 | 34 | $0 (2024) |
| ITI, Inc. | $616.78 | 5 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $532.12 | 17 | $0 (2018) |
| Neos Therapeutics, LP | $514.42 | 26 | $0 (2024) |
| Axsome Therapeutics, Inc. | $488.76 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,331 | 40 | Lundbeck LLC ($331.78) |
| 2023 | $1,350 | 32 | Axsome Therapeutics, Inc. ($241.44) |
| 2022 | $1,868 | 33 | ABBVIE INC. ($450.40) |
| 2021 | $2,154 | 30 | Alkermes, Inc. ($713.39) |
| 2020 | $527.00 | 9 | Alkermes, Inc. ($250.00) |
| 2019 | $2,559 | 35 | Janssen Pharmaceuticals, Inc ($968.62) |
| 2018 | $2,309 | 39 | Otsuka America Pharmaceutical, Inc. ($554.45) |
| 2017 | $3,032 | 44 | Otsuka America Pharmaceutical, Inc. ($876.55) |
All Payment Transactions
262 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.92 | General |
| Category: PSYCHIATRY | ||||||
| 12/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $4.29 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $120.27 | General |
| Category: Neuropsychiatry | ||||||
| 12/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/22/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $24.12 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 10/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.03 | General |
| Category: PSYCHIATRY | ||||||
| 10/10/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $5.41 | General |
| Category: PSYCHIATRY | ||||||
| 10/03/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 09/26/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: CNS | ||||||
| 09/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.79 | General |
| Category: PSYCHIATRY | ||||||
| 09/13/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 08/13/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.08 | General |
| Category: PSYCHIATRY | ||||||
| 08/09/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 07/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.50 | General |
| Category: PSYCHIATRY | ||||||
| 07/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $3.33 | General |
| Category: PSYCHIATRY | ||||||
| 07/04/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $25.53 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 06/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 06/18/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $113.96 | General |
| Category: CNS | ||||||
| 06/18/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.15 | General |
| Category: PSYCHIATRY | ||||||
| 06/14/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: CNS | ||||||
| 06/12/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/04/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $28.70 | General |
| Category: PSYCHIATRY | ||||||
| 05/24/2024 | Neos Therapeutics, LP | Adzenys XR-ODT (Drug) | Food and Beverage | Cash or cash equivalent | $22.82 | General |
| Category: ADHD | ||||||
| 05/22/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $26.45 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 409 | 1,960 | $329,805 | $159,179 |
| 2022 | 5 | 456 | 1,836 | $264,910 | $159,383 |
| 2021 | 5 | 441 | 1,510 | $191,250 | $133,881 |
| 2020 | 5 | 425 | 1,466 | $168,920 | $106,599 |
Total Patients
1,731
Total Services
6,772
Medicare Billing
$559,041
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 76 | 838 | $125,700 | $69,673 | 55.4% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 76 | 836 | $125,400 | $51,183 | 40.8% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 169 | 170 | $61,200 | $29,425 | 48.1% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 55 | 75 | $10,125 | $4,922 | 48.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 33 | 41 | $7,380 | $3,975 | 53.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 69 | 742 | $91,985 | $63,517 | 69.1% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 69 | 742 | $91,985 | $47,468 | 51.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 215 | 216 | $64,300 | $38,866 | 60.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 66 | 94 | $10,340 | $6,048 | 58.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 37 | 42 | $6,300 | $3,484 | 55.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 68 | 585 | $61,870 | $48,954 | 79.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 217 | 219 | $51,990 | $39,153 | 75.3% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 68 | 585 | $61,870 | $37,249 | 60.2% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 59 | 85 | $10,200 | $5,443 | 53.4% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 29 | 36 | $5,320 | $3,081 | 57.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 57 | 547 | $54,700 | $36,383 | 66.5% |
| 90833 | Psychotherapy, 30 minutes | Office | 2020 | 57 | 550 | $55,000 | $33,609 | 61.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 178 | 179 | $39,380 | $24,438 | 62.1% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2020 | 112 | 167 | $16,850 | $10,301 | 61.1% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2020 | 21 | 23 | $2,990 | $1,868 | 62.5% |
About Dr. Sergei Belkin, MD
Dr. Sergei Belkin, MD is a Psychiatry healthcare provider based in Glen Cove, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1083609762.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sergei Belkin, MD has received a total of $15,130 in payments from pharmaceutical and medical device companies, with $1,331 received in 2024. These payments were reported across 262 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($15,068).
As a Medicare-enrolled provider, Belkin has provided services to 1,731 Medicare beneficiaries, totaling 6,772 services with total Medicare billing of $559,041. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Glen Cove, NY
- Active Since 09/19/2005
- Last Updated 10/12/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1083609762
Products in Payments
- INGREZZA (Drug) $2,170
- REXULTI (Drug) $1,629
- VRAYLAR (Drug) $1,308
- ARISTADA (Drug) $1,304
- INVEGA SUSTENNA (Drug) $1,162
- ABILIFY MAINTENA (Drug) $1,038
- Aristada 441 mg (Drug) $925.85
- LYBALVI (Drug) $791.16
- SPRAVATO (Drug) $785.73
- CAPLYTA (Drug) $616.78
- LATUDA (Drug) $532.12
- INVEGA TRINZA (Drug) $514.70
- Adzenys XR-ODT (Drug) $514.42
- Auvelity (Drug) $488.76
- AUSTEDO (Drug) $425.69
- TRINTELLIX (Drug) $308.22
- NAMZARIC (Drug) $131.14
- NUPLAZID (Drug) $125.27
- QELBREE (Drug) $117.21
- HETLIOZ (Drug) $95.81
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Glen Cove
Rozaliya Vernikov, M.d, M.D
Psychiatry — Payments: $29,582
Psychiatry $29,582
Marianna Dogot, M.d, M.D
Psychiatry — Payments: $11,507
Psychiatry $11,507
James Thompson, Md, MD
Psychiatry — Payments: $381.36
Psychiatry $381.36
Dr. Jose Pugliese, M.d, M.D
Psychiatry — Payments: $156.10
Psychiatry $156.10
Celeste Spencer-Holmes
Psychiatry — Payments: $46.91
Psychiatry $46.91
Michael Gordon, Md, MD
Psychiatry — Payments: $26.68
Psychiatry $26.68